Development of a Lateral Flow Assay for the Detection of the Hepatitis C Virus Core Antigen

Erick Joan Vidal-Alcántara1, Sonia Hernández Antón2, Paloma Rueda2

  • 1Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Insights

A new lateral flow assay detects hepatitis C core antigen (HCVcAg), offering a rapid and cost-effective screening tool. This assay enhances accessibility for hepatitis C virus (HCV) testing, particularly in resource-limited settings.

Area of Science:

  • Virology
  • Immunology
  • Biotechnology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Current diagnostic methods for HCV are complex, expensive, and have limited accessibility.

Purpose of the Study:

  • To develop a lateral flow immunochromatography assay for detecting hepatitis C core antigen (HCVcAg).
  • To create a rapid, cost-effective, and user-friendly diagnostic tool for HCV screening.

Main Methods:

  • Utilized a double antibody sandwich format with four specific monoclonal antibodies.
  • Evaluated latex and colloidal gold as detector nanoparticles.
  • Tested recombinant HCVcAg from five genotypes and assessed matrix effects in serum samples.

Main Results:

  • Identified optimal antibody pairs through evaluation of 32 combinations.
  • Developed the LN17 assay with a target sensitivity of 10 ng/strip.
  • Gained insights into matrix effects for improved clinical application.

Conclusions:

  • The developed assay shows potential for rapid and cost-effective HCV screening.
  • The assay can improve accessibility to hepatitis C testing in high-risk populations and resource-limited areas.
Abstract